Skip to main content

FORMULACION DE PRODUCTOS ALIMENTARIOS PARA LA PREVENCION Y EL TRATAMIENTO DIRIGIDO DE ENFERMEDADES CRONICAS RELACIONADAS CON EL METABOLISMO.

AGL2016-76736-C3-3-R

•
Funding agency name Agencia Estatal de Investigación
Funding agency acronym AEI
Program Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Call Proyectos I+D+i Retos de Investigación
Call year 2016
State Plan 2013-2016 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre FUNDACION IMDEA NUTRICIÓN

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Contribución de congreso (ConferenceOutput)

Marigold supercritical extracts as a potencial anticancer agent

  • Mouhid, Lamia
  • Gómez de Cedrón, Marta
  • García-Risco, Mónica R.
  • Reglero, Guillermo
  • Fornari, Tiziana
  • Ramírez de Molina, Ana
Resumen del trabajo presentado a las III Jornadas Científicas CIAL Fórum, celebradas del 22 al 23 de noviembre de 2018 en el Instituto de Investigación en Ciencias de la Alimentación (CIAL)., Calendula officinalis, commonly known as marigold, has been used in traditional medicine for its anti-inflammatory and antiseptic virtues, and against gastric spasms. Here, we had obtained marigold extracts through supercritical CO2 extraction (SFE) and through ultrasonic assisted extraction (UAE), and we had characterized their bioactivity in the framework of cancer. We have found that marigold UAE extracts have a higher content of phenolic and flavonoid than marigold SFE extract, as well as a higher antioxidant activity. On the contrary, marigold SFE extract has a stronger cytotoxic and antiproliferative activity against pancreatic tumor-derived cells, being independent to its antioxidant effect. These results suggest that marigold SFE could be considered for further studies as a potential nutritional supplement which could improve current cancer therapies., This work has been supported by the Spanish MINECO (AGL2016-76736-C3-3-R MINECO/FEDER), Regional government Comunidad de Madrid (P2013/ABI-2728, ALIBIRD-CM) and EU Structural Funds., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Contribución de congreso (ConferenceOutput)

Effect of yarrow supercritical extract as a novel approach to pancreatic cancer treatment

  • Mouhid, Lamia
  • Gómez de Cedrón, Marta
  • Reglero, Guillermo
  • Fornari, Tiziana
  • Ramírez de Molina, Ana
Trabajo presentado a la IX Reunión de Expertos en Tecnologías de Fluidos Comprimidos (Flucomp), celebrada en el Campus UAM Cantoblanco (Madrid) del 13 al 15 junio 2018., Pancreatic cancer is one of the most aggressive tumors which occurrence is linked, together with genetic factors, to diet and lifestyle. Trying to potentiate the use of natural derived products from diet, here we propose a supercritical extract (SFE) as a nutritional supplement for cancer treatment. Yarrow SFE has demonstrated to be cytotoxic for pancreatic cancer cells (MIA PaCa-2), and able to brake 3D-sphere growth. In addition, it causes cell death through caspase 3/7 activation and therefore, triggering apoptosis. Moreover, treating MIA PaCa-2 with a chemotherapeutical agent used in clinic (5-Fluorouracil) after sensitizing them with Yarrow SFE has shown a synergetic effect between both. Finally, in a xenograft model, it has shown that animals who received Yarrow SFE extract develop a smaller tumor. In summary, our results indicate that Yarrow supercritical extract is a promising antitumoral co-adjuvant in pancreatic cancer treatment., L. Mouhid acknowledges the predoctoral contract given by IMDEA Food Institute, Spain. This work has been supported by the Spanish MINECO (AGL2016-76736-C3-3- R MINECO/FEDER), Regional government Comunidad de Madrid (P2013/ABI- 2728, ALIBIRD-CM) and EU Structural Funds., Peer reviewed